Mereo BioPharma (MREO) - Net earnings per share (EPS TTM)

Symbol and logo of brand Mereo BioPharma Group plc (MREO)

Mereo BioPharma is scaling the development of orphan drugs through strategic alliances, while the TTM earnings per share chart on GURU.Markets shows that this metric equals -0.17. Business growth relies on the automation of substance synthesis with physician-monitored testing, and medium-term potential is driven by the expected results of the final phase trials for its drug treating osteogenesis imperfecta.

MREO (mereobiopharma.com) Earnings per share for the last 12 months history from 07/04/2022 to 11/12/2026

Comprehensive metric breakdowns and analytics for Mereo BioPharma Group (MREO)

- share price and expert price forecast:
Stock Quotes Mereo BioPharma Group PLC|MREO - Forecast Levels Chart
- market capitalization indicators:
Market Capitalization Mereo BioPharma Group plc|MREO - Total Enterprise Value
- business book valuation details:
Book Value per Share Mereo BioPharma|MREO - Accounting Capitalization|Market Cap to Net Assets Ratio mereobiopharma.com|MREO - Aggregate Asset Value
- debt and liquidity details:
Debt to Equity Mereo BioPharma|MREO - Long-Term Liabilities to Equity|Short-Term Debt to Capital Mereo BioPharma Group PLC|MREO - Aggregate Debt Obligations|Debts to Book Capitalization Mereo BioPharma Group plc|MREO - Company Long-Term Debts|Company Short-Term Debt Mereo BioPharma|Quick Liquidity mereobiopharma.com
- net income and valuation multiples indicators:
MREO - Net Income|Projected Future Earnings Mereo BioPharma|MREO - P/E Multiple|Future Price to Earnings Mereo BioPharma Group PLC|MREO - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Mereo BioPharma Group plc|MREO - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Mereo BioPharma|MREO - Earnings per share for the trailing year|Quarterly EPS earnings growth mereobiopharma.com|MREO - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Mereo BioPharma
General company analysis:mereobiopharma.com (MREO)
Mass-produced product of Mereo BioPharma Group

The development of orphan drugs by Mereo BioPharma (MREO) possesses exceptional macro-resilience, as demand for specialized therapies remains independent of economic cycles and seasonality. The earnings per share trend over the last four quarters reflects the ultimate efficiency of capital management, allowing investors to assess the real profitability of the business per share and forecast the stability of the asset's market capitalization.

Competitors of Mereo BioPharma (MREO)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp (UTHR)|BMRN (BioMarin Pharma) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio Corp)|Net earnings per share for the last 12 months BGM (BGM Group Ltd)|COGT (cogentbio.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Xeris Biopharma Holdings XERS|KROS (Keros Therapeutics Inc) - Earnings per one share for the last 12 months|Arcturus Pharma - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ETON (Eton Corp)|KMDA: Net earnings per share (EPS TTM)|fulcrumtx.com (FULC) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Abeona Therapeutics, Inc.|PLX: Earnings per share for the trailing year|Earnings per share for the last twelve months Pliant Therapeutics (PLRX)|Net earnings per share for the last 12 months appliedtherapeutics.com APLT|Net earnings per share (EPS TTM) RNTX (Rein Therapeutics Inc)|Net earnings per share (EPS TTM) Gelteq Ltd GELS|AYTU - Earnings per share for the last twelve months|Chemomab Therapeutics (CMMB) - Net earnings per share for the last 12 months|SRXH: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Polyrizon (PLRZ)|Earnings per share for the last twelve months Aeterna Zentaris Inc|CYTH: Earnings per share for the trailing year|Net earnings per share (EPS TTM) INZY|RPHM - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Aeterna Zentaris CSCI